phrykt

Exagen Inc. (XGN): who owns it and who trades it

As of Nov 16, 2026, XGN insiders reported 8 open-market sales worth $1.3M and 4 purchases worth $569K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Jorey Chernett (10% owner), with $815K. 4 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Exagen

From the latest filings

Overall: about as much buying as selling. Funds and insiders mostly sold. Famous investors mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns XGN

57 funds and institutions reported XGN shares worth $38.4M at the end of Q2 2026, about 34% of the company. The largest holder is Wexford Capital LP with 3.3%.

Funds and institutions (13F) 34%Everyone else 66%

10 largest owners, by share of the company

Wexford Capital LP3.3%
Nano Cap New Millennium Growth Fund L P2.8%
First Eagle Investment Management, LLC2.6%
Vanguard Capital Management LLC2.5%
FourWorld Capital Management LLC2.5%
Silvercrest Asset Management Group LLC2.1%
Kennedy Capital Management LLC2.0%
Mink Brook Asset Management LLC2.0%
Jane Street Group, LLC1.3%
Acadian Asset Management LLC1.3%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Wexford Capital LP792,8553.30%$3.7MNo change
Nano Cap New Millennium Growth Fund L P675,0002.81%$3.1M+15%
First Eagle Investment Management, LLC613,9302.55%$2.9M+390%
Vanguard Capital Management LLC612,8322.55%$2.8M-10%
FourWorld Capital Management LLC596,5282.48%$2.8M+36%
Silvercrest Asset Management Group LLC514,7612.14%$2.4M-4%
Kennedy Capital Management LLC485,0482.02%$2.3M-2%
Mink Brook Asset Management LLC475,9441.98%$2.2M+29%
Jane Street Group, LLC322,5021.34%$1.5M+36%
Acadian Asset Management LLC310,0841.29%$1.4M-55%
Marshall Wace, LLP306,7031.28%$1.4M+1024%
Flputnam Investment Management Co288,8101.20%$1.3MNew
Gsa Capital Partners LLP214,7210.89%$998K-15%
Rtw Investments, LP195,0000.81%$907K-51%
Geode Capital Management, LLC185,6540.77%$864K+4%
Man Group plc167,2920.70%$778K+29%
BlackRock, Inc.142,6250.59%$663K+13%
Perceptive Advisors LLC114,8930.48%$534KNo change
XTX Topco Ltd111,9480.47%$521K-54%
Sei Investments Co109,0050.45%$507K-55%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, XGN insiders reported $569K of open-market purchases and $1.3M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$569K
4 trades, 1 people
Sales, 12 months
$1.3M
8 trades, 3 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Nov 13, 2026
Filed Nov 13, 2026

Purchases and sales by month

$815K$815KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 13, 2026Jorey Chernett10% ownerSale58,068$4.08$237KForm 4
Nov 12, 2026Jorey Chernett10% ownerSale109,436$4.65$509KForm 4
Nov 11, 2026Jorey Chernett10% ownerPurchase71,315$5.23$373KForm 4
Nov 10, 2026Jorey Chernett10% ownerPurchase7,085$5.26$37.3KForm 4
Nov 9, 2026Jorey Chernett10% ownerPurchase8,500$6.35$54KForm 4
Nov 6, 2026Jorey Chernett10% ownerSale11,265$6.14$69.2KForm 4
Oct 19, 2026Jorey Chernett10% ownerPurchase14,000$7.46$104KForm 4
Oct 16, 2026John AballiCEOSale34,294$7.87$270KForm 4
Sep 1, 2026Jeffrey G. BlackCFOSale20,614$7.22$149KForm 4
Mar 3, 2026John AballiCEOSale15,698$3.62$56.8KForm 4
Feb 24, 2026John AballiCEOSale11,430$3.61$41.3KForm 4
Feb 24, 2026Jeffrey G. BlackCFOSale1,584$3.61$5.7KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Jorey Chernett10% owner$569K$815KNov 13, 2026
John AballiPresident and CEO, Director–$368KOct 16, 2026
Jeffrey G. BlackChief Financial Officer–$155KSep 1, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

XGN short interest

Low short interest. 3.0% of XGN shares are sold short: about 1 share in 33. Over the last 12 reports the number of shares short went up 2%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 727,455 XGN shares were sold short, 3.0% of the shares outstanding, up 8.0% from the report before. At the average daily volume of 366,878 shares, buying them all back would take about 2.0 trading days (days to cover).

Shares short, % of all shares

3.00%May 15Oct 304.29%

Days to cover

2.0May 15Oct 305.0

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026727,4553.00%+8%366,8782.0
Oct 15, 2026673,8502.78%-4%370,0131.8
Sep 30, 2026704,6342.91%-12%286,3722.5
Sep 15, 2026800,3443.30%-7%223,1963.6
Aug 31, 2026864,0383.57%-8%339,5032.5
Aug 14, 2026940,4323.88%+4%625,5821.5
Jul 31, 2026903,8763.73%-8%216,6674.2
Jul 15, 2026978,9804.07%+20%218,5624.5
Jun 30, 2026813,3683.38%+28%238,2083.4
Jun 15, 2026633,3652.63%-27%339,8171.9
May 29, 2026864,7423.60%+21%472,0521.8
May 15, 2026716,1542.98%-1%854,1431.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Exagen company events

Exagen filed 7 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 10, 2026.

  1. Nov 10, 2026ResultsReleased financial results. Filing
  2. Aug 4, 2026ResultsReleased financial results. Filing
  3. Jun 9, 2026VoteReported shareholder vote results. Filing
  4. May 11, 2026ResultsReleased financial results. Filing
  5. Apr 23, 2026LeadershipAna Hooker notified the Board of Directors of Exagen Inc. of her decision to resign as member of the Board, including all committees thereof, effective April 17, 2026. Filing
  6. Mar 10, 2026ResultsReleased financial results. Filing
  7. Jan 12, 2026AnnouncementThe following information contained in the Press Release is deemed “filed” for purposes of Section 18 of the Exchange Act and deemed incorporated by reference into this Item 8.01: • The information included under the headings “Select Preliminary Unaudited 2025 Results,” “Cautionary Note Regarding… Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Exagen financials

Famous investors that hold XGN

4 of the 50 well-known investors we track reported holding XGN in their latest 13F filing. The largest position is Ken Griffin's, worth $2.2M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 2026273,804$2.2M0.0%+1802%
Israel Englander · Millennium ManagementQ3 2026127,817$1M0.0%New
Jim Simons · Renaissance TechnologiesQ3 202659,382$483K0.0%+50%
Steve Cohen · Point72 Asset ManagementQ3 202616,267$132K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named XGN in the last 120 days.

FiledHolderFormStake
Nov 13, 2026Chernett Jorey13G/A3.5%
Nov 13, 2026NMSIC Co-Investment Fund, L.P.13G/A3.4%
Nov 13, 2026Chernett Jorey13G/A3.5%
Nov 13, 2026NMSIC Co-Investment Fund, L.P.13G/A3.4%

Questions about Exagen Inc. (XGN) stock

Who owns the most XGN stock?

The largest reported owner of Exagen Inc. (XGN) is Wexford Capital LP, with 3.3% of the company. In total, 57 funds and institutions reported holding XGN at the end of Q2 2026, together about 34% of the shares. See the largest owners.

Are XGN insiders buying or selling?

In the last 12 months, XGN insiders reported 4 open-market purchases worth $569K and 8 sales worth $1.3M. The latest trade was on Nov 13, 2026. See every trade.

What is the short interest in XGN?

As of Oct 30, 2026, 727,455 XGN shares were sold short, 3.0% of the shares outstanding, up 8.0% from the report before. At the average daily volume of 366,878 shares, buying them all back would take about 2.0 trading days (days to cover). See the history.

Which famous investors hold XGN?

4 of the 50 well-known investors we track reported XGN in their latest 13F filing, including Ken Griffin, Israel Englander, Jim Simons. The largest position is worth $2.2M. See all holders.

Executive pay

Exagen's chief executive was paid a total of $1.4M for the year ended Dec 31, 2025, up 18% from $1.2M the year before. In the last 12 months, Exagen's executives and directors bought no stock on the open market and sold $522K.

Chief executive, total pay$1.4MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$2.9MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$746KThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.